Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC

NCT: NCT05709782 · RECRUITING

NCT IDNCT05709782
StatusRECRUITING
Start Date2023-05-09
Completion2029-01-13
SponsorM.D. Anderson Cancer Center (OTHER)
First posted
Last updated

Brief Summary

To learn whether giving spinal stereotactic radiosurgery (SRSS) that uses a more advanced imaging scan method called Magnetic Resonance imaging with a Linear Accelerator (MR-LINAC) during treatment will lead to improved responses to treatment and better quality of life. SRSS is radiation therapy given to the area around your spine.

Frequently Asked Questions

What is Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC?

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC is a clinical trial registered under NCT05709782. Current status: RECRUITING.

What is the status of NCT05709782?

The current status of NCT05709782 (Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC) is: RECRUITING.

When did Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC start?

Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC started on 2023-05-09.

Related Devices

K182050Linear Accelerator Control Console Software v13.1.010 Update, syngo Radiation Therapy Therapist v4.3.1_MR3 Patch, syngo Radiation Therapy Oncologist v4.3.1_MR3 PatchSiemens Medical Solutions USA, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑